Literature DB >> 1692541

Antibodies to the beta-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood.

R A Stern1, J Q Trojanowski, V M Lee.   

Abstract

Antibodies to the Alzheimer disease (AD) beta-amyloid peptide (beta AP) were used to identify beta AP precursor fragments in blood. The antibodies detected 3 major polypeptides with apparent molecular weights (MW) of 47-64,000 in Western blots of plasma derived clot proteins, but these proteins corresponded to human A-alpha, B-beta and gamma-fibrinogen since they reacted with 2 different anti-fibrinogen antisera, and the anti-beta AP and anti-fibrinogen antibodies recognized purified fibrinogen and fibrin. These data are significant for efforts to develop immunochemical assays to diagnose and monitor the progression of AD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692541     DOI: 10.1016/0014-5793(90)80760-g

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Complex pharmacokinetics of a humanized antibody against human amyloid beta peptide, anti-abeta Ab2, in nonclinical species.

Authors:  Yulia Vugmeyster; Pam Szklut; David Wensel; John Ross; Xin Xu; Michel Awwad; Davinder Gill; Lioudmila Tchistiakov; Garvin Warner
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

2.  Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

Authors:  H Funato; M Yoshimura; T Yamazaki; T C Saido; Y Ito; J Yokofujita; R Okeda; Y Ihara
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 3.  The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

Authors:  William E Van Nostrand
Journal:  Biochim Biophys Acta       Date:  2015-10-27

Review 4.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 5.  Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review.

Authors:  Maria Fernanda Avila-Vazquez; Nelly F Altamirano-Bustamante; Myriam M Altamirano-Bustamante
Journal:  Molecules       Date:  2017-12-29       Impact factor: 4.411

Review 6.  Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns.

Authors:  Orla Cunningham; Martin Scott; Zhaohui Sunny Zhou; William J J Finlay
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 7.  The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesium.

Authors:  Boguslaw Lipinski; Etheresia Pretorius
Journal:  Front Hum Neurosci       Date:  2013-10-29       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.